Precision Medicine Collaboration and Licensing Deals 2019-2024
January 16, 2025 06:03 ET
|
Research and Markets
Dublin, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The "Precision Medicine Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering. This report contains a...
Silexion Therapeutics Announces Pricing of $5.0 Million Public Offering
January 15, 2025 20:00 ET
|
Silexion Therapeutics Corp
Cayman Islands, January 15, 2025 -- Silexion Therapeutics Corp (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for...
Silexion Therapeutics Announces Additional Promising Preclinical Data for SIL-204, Demonstrating Impressive Synergy with First-Line Pancreatic Cancer Chemotherapies
January 15, 2025 16:01 ET
|
Silexion Therapeutics Corp
Cayman Islands, January 15, 2025 – Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven...
Silexion Therapeutics to Present SIL-204 Data in KRAS-Driven Pancreatic Cancer at the 2025 ASCO Gastrointestinal Cancers Symposium
January 13, 2025 07:50 ET
|
Silexion Therapeutics Corp
Cayman Islands, January 13, 2025 -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven...
Biosimulation Market Research Report 2024-2030: Expanding Applications in Defence, Industrial Bioprocessing, Nutraceuticals, and Agri-food Production
January 09, 2025 07:38 ET
|
Research and Markets
Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Biosimulation Market (2024 Edition): Analysis By Type (Services, Software), By Application, By Deployment Model Outlook, By Region, By Country: Market...
PARP Inhibitor Biomarkers Market Review 2024 and Forecast 2025-2035: Breast Cancer Applications Lead in Revenue, While Ovarian Cancer Emerges as the Fastest-Growing Opportunity
January 09, 2025 04:26 ET
|
Research and Markets
Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "PARP Inhibitor Biomarkers Market by Product, Service, Application, End User, and Region" report has been added to ResearchAndMarkets.com's offering....
Gene Panel Market Trends and Competition Analysis, Forecast to 2034 - Customized Gene Panels and Cancer Risk Assessments Lead the Charge in Gene Panel Market Expansion
January 08, 2025 11:22 ET
|
Research and Markets
Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "Gene Panel Market by Product & Services, Techniques, Design, Application, End User, and Region" report has been added to ResearchAndMarkets.com's...
Precision Medicine in Oncology Collaboration and Licensing Deals Analysis Report 2024 with Directory of 821 Deals Signed Since 2016 by Company A-Z, Deal Type and Therapeutic Target
January 03, 2025 10:59 ET
|
Research and Markets
Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. This report...
Silexion Therapeutics collaborates with Evonik on advanced siRNA Formulation Development
December 17, 2024 06:30 ET
|
Silexion Therapeutics Corp
Cayman Islands, December 17, 2024 – Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven...
Cell Free DNA (cfDNA) Testing Market Outlook to 2028 & 2033 - Projected to Generate Revenues of $20.63 Billion by 2028, Fueled by Advances in Liquid Biopsy and Personalized Medicine
December 13, 2024 09:49 ET
|
Research and Markets
Dublin, Dec. 13, 2024 (GLOBE NEWSWIRE) -- The "Cell Free DNA (cfDNA) Testing Market Outlook to 2028 & 2033" report has been added to ResearchAndMarkets.com's offering.The cell free DNA (cfDNA)...